Cargando…
Association between Genetically Proxied Inhibition of HMG-CoA Reductase and Age at Onset of Huntington’s Disease
Background: Previous studies have found that statins may play a potential role in the age at onset (AAO) of Huntington’s disease (HD). We performed this Mendelian randomization (MR) study to assess the association between genetically proxied inhibition of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-C...
Autores principales: | Zhu, Yahui, Li, Mao, Wang, Hongfen, Yang, Fei, Wang, Jiao, Huang, Xusheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688104/ https://www.ncbi.nlm.nih.gov/pubmed/36421875 http://dx.doi.org/10.3390/brainsci12111551 |
Ejemplares similares
-
Metabolomic Profiling of Statin Use and Genetic Inhibition of HMG-CoA Reductase
por: Würtz, Peter, et al.
Publicado: (2016) -
Chronic Onset Form of Anti-HMG-CoA Reductase Myopathy
por: Lorenzo-Villalba, Noel, et al.
Publicado: (2021) -
Associations of genetically proxied inhibition of HMG-CoA reductase, NPC1L1, and PCSK9 with breast cancer and prostate cancer
por: Sun, Lulu, et al.
Publicado: (2022) -
Predictive Modeling
of HMG-CoA Reductase Inhibitory
Activity and Design of New HMG-CoA Reductase Inhibitors
por: Samizo, Shigeyoshi, et al.
Publicado: (2023) -
Genetically proxied antidiabetic drugs targets and stroke risk
por: Zhu, Yahui, et al.
Publicado: (2023)